• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重症肌无力患者的肠道真菌微生物群:MYBIOM研究的亚分析

Fungal Gut Microbiome in Myasthenia Gravis: A Sub-Analysis of the MYBIOM Study.

作者信息

Verhasselt Hedda Luise, Ramakrishnan Elakiya, Schlag Melina, Marchesi Julian R, Buer Jan, Kleinschnitz Christoph, Hagenacker Tim, Totzeck Andreas

机构信息

Institute of Medical Microbiology, University Hospital Essen, University of Duisburg-Essen, D-45122 Essen, Germany.

Department of Neurology and Center for Translational Neuro- and Behavioral Sciences (C-TNBS), University Hospital Essen, University of Duisburg-Essen, D-45122 Essen, Germany.

出版信息

J Fungi (Basel). 2023 May 13;9(5):569. doi: 10.3390/jof9050569.

DOI:10.3390/jof9050569
PMID:37233280
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10218993/
Abstract

An altered gut microbiota is a possible contributing pathogenic factor in myasthenia gravis (MG), an autoimmune neuromuscular disease. However, the significance of the fungal microbiome is an understudied and neglected part of the intestinal microbiome in MG. We performed a sub-analysis of the MYBIOM study including faecal samples from patients with MG ( = 41), non-inflammatory neurological disorder (NIND, = 18), chronic inflammatory demyelinating polyradiculoneuropathy (CIDP, = 6) and healthy volunteers (n = 12) by sequencing the internal transcribed spacer 2 (ITS2). Fungal reads were obtained in 51 out of 77 samples. No differences were found in alpha-diversity indices computed between the MG, NIND, CIDP and HV groups, indicating an unaltered fungal diversity and structure. Overall, four mould species ( and ) and five yeast species ( and ) were identified. Besides one MG patient with abundant , no prominent dysbiosis in the MG group of the mycobiome was found. Not all fungal sequences within all groups were successfully assigned, so further sub-analysis was withdrawn, limiting robust conclusions.

摘要

肠道微生物群改变可能是重症肌无力(MG)这一自身免疫性神经肌肉疾病的致病因素之一。然而,真菌微生物群的重要性在MG肠道微生物群中是一个研究不足且被忽视的部分。我们对MYBIOM研究进行了一项子分析,通过对内部转录间隔区2(ITS2)进行测序,纳入了MG患者(n = 41)、非炎性神经系统疾病(NIND,n = 18)、慢性炎性脱髓鞘性多发性神经根神经病(CIDP,n = 6)和健康志愿者(n = 12)的粪便样本。77个样本中有51个获得了真菌读数。在MG、NIND、CIDP和健康志愿者组之间计算的α多样性指数未发现差异,表明真菌多样性和结构未改变。总体而言,鉴定出了四种霉菌(和)和五种酵母(和)。除了一名MG患者的含量丰富外,在MG组的真菌微生物群中未发现明显的生态失调。并非所有组内的真菌序列都成功分类,因此撤回了进一步的子分析,这限制了得出有力结论。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c95/10218993/b5d621bc67d8/jof-09-00569-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c95/10218993/449aa058a9fd/jof-09-00569-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c95/10218993/07d0a4ad3539/jof-09-00569-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c95/10218993/b5d621bc67d8/jof-09-00569-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c95/10218993/449aa058a9fd/jof-09-00569-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c95/10218993/07d0a4ad3539/jof-09-00569-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c95/10218993/b5d621bc67d8/jof-09-00569-g003.jpg

相似文献

1
Fungal Gut Microbiome in Myasthenia Gravis: A Sub-Analysis of the MYBIOM Study.重症肌无力患者的肠道真菌微生物群:MYBIOM研究的亚分析
J Fungi (Basel). 2023 May 13;9(5):569. doi: 10.3390/jof9050569.
2
Gut bacterial microbiota in patients with myasthenia gravis: results from the MYBIOM study.重症肌无力患者的肠道细菌微生物群:MYBIOM研究结果
Ther Adv Neurol Disord. 2021 Aug 11;14:17562864211035657. doi: 10.1177/17562864211035657. eCollection 2021.
3
The gut mycobiome of the Human Microbiome Project healthy cohort.人类微生物组计划健康队列的肠道共生真菌组。
Microbiome. 2017 Nov 25;5(1):153. doi: 10.1186/s40168-017-0373-4.
4
Gut mycobiome dysbiosis and its impact on intestinal permeability in attention-deficit/hyperactivity disorder.肠道共生真菌失调及其对注意缺陷多动障碍肠道通透性的影响。
J Child Psychol Psychiatry. 2023 Sep;64(9):1280-1291. doi: 10.1111/jcpp.13779. Epub 2023 Apr 5.
5
Gut fungal dysbiosis and altered bacterial-fungal interaction in patients with diarrhea-predominant irritable bowel syndrome: An explorative study.肠真菌失调和腹泻为主的肠易激综合征患者细菌-真菌相互作用改变:一项探索性研究。
Neurogastroenterol Motil. 2020 Nov;32(11):e13891. doi: 10.1111/nmo.13891. Epub 2020 May 25.
6
Characterization of the intestinal fungal microbiome in patients with hepatocellular carcinoma.肝细胞癌患者肠道真菌微生物组的特征。
J Transl Med. 2023 Feb 15;21(1):126. doi: 10.1186/s12967-023-03940-y.
7
Characterization of fungal dysbiosis in Japanese patients with inflammatory bowel disease.日本炎症性肠病患者真菌失调的特征。
J Gastroenterol. 2019 Feb;54(2):149-159. doi: 10.1007/s00535-018-1530-7. Epub 2018 Nov 26.
8
Effect of HIV/HAART and Other Clinical Variables on the Oral Mycobiome Using Multivariate Analyses.采用多变量分析探讨 HIV/HAART 及其他临床变量对口腔微生物组的影响。
mBio. 2021 Mar 23;12(2):e00294-21. doi: 10.1128/mBio.00294-21.
9
Metabolic disorder and intestinal microflora dysbiosis in chronic inflammatory demyelinating polyradiculoneuropathy.慢性炎症性脱髓鞘性多发性神经根神经病中的代谢紊乱与肠道微生物群失调
Cell Biosci. 2023 Jan 11;13(1):6. doi: 10.1186/s13578-023-00956-1.
10
A case of myasthenia gravis in childhood associated with chronic inflammatory demyelinating polyradiculoneuropathy.一例儿童重症肌无力合并慢性炎症性脱髓鞘性多发性神经根神经病。
Neuropediatrics. 1998 Apr;29(2):108-12. doi: 10.1055/s-2007-973544.

本文引用的文献

1
Gut microbiota and metabolites in myasthenia gravis: Early diagnostic biomarkers and therapeutic strategies.重症肌无力中的肠道微生物群和代谢产物:早期诊断生物标志物及治疗策略
Clin Immunol. 2022 Dec;245:109173. doi: 10.1016/j.clim.2022.109173. Epub 2022 Nov 14.
2
The gut mycobiome in health, disease, and clinical applications in association with the gut bacterial microbiome assembly.肠道真菌组在健康、疾病以及与肠道细菌微生物组组装相关的临床应用。
Lancet Microbe. 2022 Dec;3(12):e969-e983. doi: 10.1016/S2666-5247(22)00203-8. Epub 2022 Sep 28.
3
Multiple sclerosis patients have an altered gut mycobiome and increased fungal to bacterial richness.
多发性硬化症患者的肠道微生物组发生改变,真菌与细菌丰富度比值增加。
PLoS One. 2022 Apr 26;17(4):e0264556. doi: 10.1371/journal.pone.0264556. eCollection 2022.
4
Analyzing the human gut mycobiome - A short guide for beginners.分析人类肠道真菌微生物组——初学者简短指南
Comput Struct Biotechnol J. 2022 Jan 19;20:608-614. doi: 10.1016/j.csbj.2022.01.008. eCollection 2022.
5
Alterations of the gut mycobiome in patients with MS.多发性硬化症患者肠道微生物组的改变。
EBioMedicine. 2021 Sep;71:103557. doi: 10.1016/j.ebiom.2021.103557. Epub 2021 Aug 26.
6
Gut bacterial microbiota in patients with myasthenia gravis: results from the MYBIOM study.重症肌无力患者的肠道细菌微生物群:MYBIOM研究结果
Ther Adv Neurol Disord. 2021 Aug 11;14:17562864211035657. doi: 10.1177/17562864211035657. eCollection 2021.
7
Unambiguous identification of fungi: where do we stand and how accurate and precise is fungal DNA barcoding?真菌的明确鉴定:我们目前的状况如何,真菌DNA条形码技术的准确性和精确性如何?
IMA Fungus. 2020 Jul 10;11:14. doi: 10.1186/s43008-020-00033-z. eCollection 2020.
8
Dysbiosis of Gut Fungal Microbiota in Children with Autism Spectrum Disorders.自闭症谱系障碍儿童肠道真菌微生物群失调。
J Autism Dev Disord. 2021 Jan;51(1):267-275. doi: 10.1007/s10803-020-04543-y.
9
Therapeutic Effect of Bifidobacterium Administration on Experimental Autoimmune Myasthenia Gravis in Lewis Rats.双歧杆菌对实验性自身免疫性重症肌无力大鼠的治疗作用。
Front Immunol. 2019 Dec 19;10:2949. doi: 10.3389/fimmu.2019.02949. eCollection 2019.
10
Using MicrobiomeAnalyst for comprehensive statistical, functional, and meta-analysis of microbiome data.使用 MicrobiomeAnalyst 进行微生物组数据的综合统计、功能和元分析。
Nat Protoc. 2020 Mar;15(3):799-821. doi: 10.1038/s41596-019-0264-1. Epub 2020 Jan 15.